BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10623771)

  • 1. The human herpesvirus 8 homolog of Epstein-Barr virus SM protein (KS-SM) is a posttranscriptional activator of gene expression.
    Gupta AK; Ruvolo V; Patterson C; Swaminathan S
    J Virol; 2000 Jan; 74(2):1038-44. PubMed ID: 10623771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Epstein-Barr virus (EBV) SM protein enhances pre-mRNA processing of the EBV DNA polymerase transcript.
    Key SC; Yoshizaki T; Pagano JS
    J Virol; 1998 Nov; 72(11):8485-92. PubMed ID: 9765385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of Epstein-Barr virus SM protein: identification of amino acids essential for structure, transactivation, splicing inhibition, and virion production.
    Ruvolo V; Sun L; Howard K; Sung S; Delecluse HJ; Hammerschmidt W; Swaminathan S
    J Virol; 2004 Jan; 78(1):340-52. PubMed ID: 14671116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative autoregulation of Epstein-Barr virus (EBV) replicative gene expression by EBV SM protein.
    Verma D; Ling C; Johannsen E; Nagaraja T; Swaminathan S
    J Virol; 2009 Aug; 83(16):8041-50. PubMed ID: 19515786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Epstein-Barr virus SM protein is functionally similar to ICP27 from herpes simplex virus in viral infections.
    Boyer JL; Swaminathan S; Silverstein SJ
    J Virol; 2002 Sep; 76(18):9420-33. PubMed ID: 12186924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression from the ORF50/K8 region of Kaposi's sarcoma-associated herpesvirus.
    Seaman WT; Ye D; Wang RX; Hale EE; Weisse M; Quinlivan EB
    Virology; 1999 Oct; 263(2):436-49. PubMed ID: 10544116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Epstein-Barr virus nuclear protein SM is both a post-transcriptional inhibitor and activator of gene expression.
    Ruvolo V; Wang E; Boyle S; Swaminathan S
    Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8852-7. PubMed ID: 9671768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus SM protein.
    Cook ID; Shanahan F; Farrell PJ
    Virology; 1994 Nov; 205(1):217-27. PubMed ID: 7975218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biology of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus.
    Swaminathan S
    Semin Hematol; 2003 Apr; 40(2):107-15. PubMed ID: 12704587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) encodes a homologue of the Epstein-Barr virus bZip protein EB1.
    Gruffat H; Portes-Sentis S; Sergeant A; Manet E
    J Gen Virol; 1999 Mar; 80 ( Pt 3)():557-561. PubMed ID: 10091993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of human herpesvirus 8 (HHV-8) thymidine kinase (TK) TATAA-less promoter by HHV-8 ORF50 gene product is SP1 dependent.
    Zhang L; Chiu J; Lin JC
    DNA Cell Biol; 1998 Sep; 17(9):735-42. PubMed ID: 9778032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 lytic origin of DNA replication is dependent upon a cis-acting AT-rich region and an ORF50 response element and the trans-acting factors ORF50 (K-Rta) and K8 (K-bZIP).
    AuCoin DP; Colletti KS; Cei SA; Papousková I; Tarrant M; Pari GS
    Virology; 2004 Jan; 318(2):542-55. PubMed ID: 14972523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a chemokine receptor-related gene in human herpesvirus 8 and its expression in Kaposi's sarcoma.
    Guo HG; Browning P; Nicholas J; Hayward GS; Tschachler E; Jiang YW; Sadowska M; Raffeld M; Colombini S; Gallo RC; Reitz MS
    Virology; 1997 Feb; 228(2):371-8. PubMed ID: 9123844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
    Wang SE; Wu FY; Yu Y; Hayward GS
    J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of CD21 and CD23 gene expression by Kaposi's sarcoma-associated herpesvirus RTA.
    Chang H; Gwack Y; Kingston D; Souvlis J; Liang X; Means RE; Cesarman E; Hutt-Fletcher L; Jung JU
    J Virol; 2005 Apr; 79(8):4651-63. PubMed ID: 15795251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) replication and transcription factor activates the K9 (vIRF) gene through two distinct cis elements by a non-DNA-binding mechanism.
    Ueda K; Ishikawa K; Nishimura K; Sakakibara S; Do E; Yamanishi K
    J Virol; 2002 Dec; 76(23):12044-54. PubMed ID: 12414946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spironolactone blocks Epstein-Barr virus production by inhibiting EBV SM protein function.
    Verma D; Thompson J; Swaminathan S
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3609-14. PubMed ID: 26976570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein.
    Lukac DM; Renne R; Kirshner JR; Ganem D
    Virology; 1998 Dec; 252(2):304-12. PubMed ID: 9878608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
    Ye J; Gradoville L; Daigle D; Miller G
    J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus.
    Chiou CJ; Poole LJ; Kim PS; Ciufo DM; Cannon JS; ap Rhys CM; Alcendor DJ; Zong JC; Ambinder RF; Hayward GS
    J Virol; 2002 Apr; 76(7):3421-39. PubMed ID: 11884567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.